Zobrazeno 1 - 10
of 14
pro vyhledávání: '"M van de Meeberg"'
Autor:
M. M. van de Meeberg, M. L. Seinen, H. H. Fidder, M. Lin, B. Oldenburg, N. K. de Boer, G. Bouma, R. de Jonge, M. Bulatović Ćalasan, the Dutch Initiative on Crohn and Colitis (ICC)
Publikováno v:
BMC Gastroenterology, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Methotrexate is an immunomodulatory drug for patients with Crohn’s disease. Erythrocyte MTX-polyglutamates (MTX-PG1-5) may be used for therapeutic drug monitoring (TDM) as MTX-PG is thought to mediate MTX’s efficacy. Informati
Externí odkaz:
https://doaj.org/article/de092462ed2d4ae7b0cebbc7ba757245
Autor:
Maartje M. van de Meeberg, Renske C. F. Hebing, Michael T. Nurmohamed, Herma H. Fidder, Martijn W. Heymans, Gerd Bouma, Marjolein S. de Bruin‐Weller, Janneke Tekstra, Bart van den Bemt, Robert de Jonge, Maja Bulatović Ćalasan
Publikováno v:
van de Meeberg, M M, Hebing, R C F, Nurmohamed, M T, Fidder, H H, Heymans, M W, Bouma, G, de Bruin-Weller, M S, Tekstra, J, van den Bemt, B, de Jonge, R & Bulatović Ćalasan, M 2023, ' A meta-analysis of methotrexate polyglutamates in relation to efficacy and toxicity of methotrexate in inflammatory arthritis, colitis and dermatitis ', British Journal of Clinical Pharmacology, vol. 89, no. 1, pp. 61-79 . https://doi.org/10.1111/bcp.15579
British Journal of Clinical Pharmacology, 89, 61-79
British Journal of Clinical Pharmacology, 89, 1, pp. 61-79
British Journal of Clinical Pharmacology, 89, 61-79
British Journal of Clinical Pharmacology, 89, 1, pp. 61-79
Contains fulltext : 291154.pdf (Publisher’s version ) (Open Access) AIMS: In immune-mediated inflammatory diseases (IMIDs), early symptom control is a key therapeutic goal. Methotrexate (MTX) is the first-line treatment across IMIDs. However, MTX i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7af0925734264262034ac1205557a46
https://hdl.handle.net/2066/291154
https://hdl.handle.net/2066/291154
Autor:
Maartje M. van de Meeberg, Elwin R. Verheij, Herma H. Fidder, Gerd Bouma, Alwin D.R. Huitema, Bas Oldenburg
Publikováno v:
Therapeutic Drug Monitoring.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8e767de540aba1784c233922fdb728c
https://doi.org/10.1097/ftd.0000000000001084
https://doi.org/10.1097/ftd.0000000000001084
Publikováno v:
Intelligence and National Security. 36:849-862
In 2008 a Devil's Advocate (DA) office was established within the Dutch Defence Intelligence and Security Service (DISS) to improve quality assurance and institutionalise critical reflection in its...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d020297d0dc85e0ee3191be846445543
https://doi.org/10.1080/02684527.2021.1946951
https://doi.org/10.1080/02684527.2021.1946951
Autor:
Maartje M. van de Meeberg, Rob J. Th. Ouwendijk, Pieter C. J. ter Borg, Sven J. van den Hazel, Paul C. van de Meeberg
Publikováno v:
Endoscopy International Open, Vol 04, Iss 05, Pp E572-E576 (2016)
Background and study aims: Conventional reporting of polyps is often incomplete. We tested the Polyp Manager (PM), a new software application permitting the endoscopist to document polyps in real time during colonoscopy. We studied completeness of po
Externí odkaz:
https://doaj.org/article/86d8e64ac68f46389c82454b70398188
Publikováno v:
Journal of Clinical Gastroenterology.
Goal and background A number of studies have investigated the effectiveness of cannabis or cannabinoids for treatment of inflammatory bowel diseases (IBD). We aimed to systematically analyze their effect in in the treatment of IBD patients. Study We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bc2940e19bc9d5c37b43644b5d8bbaf
https://doi.org/10.1097/mcg.0000000000001393
https://doi.org/10.1097/mcg.0000000000001393
Autor:
R. de Jonge, Gerd Bouma, M. Lin, M. Bulatović Ćalasan, M van de Meeberg, Herma H. Fidder, Margien L. Seinen, Bas Oldenburg
Publikováno v:
Journal of Crohn's and Colitis. 15:S339-S339
Background Methotrexate (MTX) is an immunomodulatory drug for patients with Crohn’s Disease (CD), used as first-line therapy, as a second-line in case of failure to thiopurine, and concomitantly with anti-TNFα agents to decrease production of anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f786da88a886b1904cdb4bf99c804da4
https://doi.org/10.1093/ecco-jcc/jjab076.436
https://doi.org/10.1093/ecco-jcc/jjab076.436
Autor:
Harm Sinnige, Peet T. G. A. Nooijen, Lauranne A A P Derikx, Loes H C Nissen, Maartje M. van de Meeberg, D. Lucette Schipper
Publikováno v:
World Journal of Gastroenterology
Hepatosplenic T-cell lymphoma (HSTCL) is a rare non-Hodgkin lymphoma with a high mortality rate. Higher incidence is reported in patients with inflammatory bowel disease, specifically in male patients that are younger than 35 years, and have been tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e4e820810dda3149d93324a7ecd721a
http://europepmc.org/articles/PMC5175260
http://europepmc.org/articles/PMC5175260
Publikováno v:
Journal of Crohn's and Colitis. 13:S335-S336
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71297b6faa5a092eb39e05fbba7a0768
https://doi.org/10.1093/ecco-jcc/jjy222.572
https://doi.org/10.1093/ecco-jcc/jjy222.572
Publikováno v:
Huisarts en wetenschap. 61:60-60
Goede voorlichting en niet-medicamenteuze adviezen vormen de hoeksteen van de behandeling van het prikkelbaredarmsyndroom (PDS). Bij onvoldoende effect kan medicamenteuze behandeling worden overwogen. De NHG-Standaard Prikkelbaredarmsyndroom bespreek
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a2ad3341c2e73bd7e2df3f70479bdf6
https://doi.org/10.1007/s12445-018-0250-9
https://doi.org/10.1007/s12445-018-0250-9